Postdiagnosis aspirin use reduces risk of dying from colorectal cancer
Wednesday, August 12, 2009 - 16:49
in Health & Medicine
Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report Harvard researchers at Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital. In today's edition of the Journal of the American Medical Association, the study’s authors also find that the aspirin-associated survival advantage was seen primarily in patients with tumors expressing the COXread more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Postdiagnosis aspirin use reduces risk of dying from colorectal cancerTue, 11 Aug 2009, 16:40:32 EDT
- Aspirin use after colorectal cancer diagnosis associated with improved survivalTue, 11 Aug 2009, 16:40:20 EDT
- Daily aspirin may reduce risk of common type of breast cancerWed, 30 Apr 2008, 14:57:29 EDT
- Hormone therapy associated with reduced colorectal cancer riskThu, 8 Jan 2009, 0:22:33 EST
- Protein levels indicate risk of death in some colorectal cancer patientsTue, 9 Dec 2008, 8:03:31 EST